Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-25-000049 General Corporate
Debt relative to revenue 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
134.62% · OPTIONAL · VALID
Capex intensity 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.40% · OPTIONAL · VALID
Operating cash generation 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-7.80% · OPTIONAL · VALID
Revenue growth 10th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-4.54% · CORE · VALID
Inventory pressure 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
59.86% · OPTIONAL · VALID
Operating margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
6.09% · CORE · VALID
R&D intensity 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.95% · OPTIONAL · VALID
SBC intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.64% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 34.75%
Current 134.62%
Delta 99.86% Capex Intensity Decreased
Previous 6.97%
Current 6.40%
Delta -0.57% Cash Generation Decreased
Previous 9.01%
Current -7.80%
Delta -16.81% Growth Decreased
Previous -1.06%
Current -4.54%
Delta -3.47% Inventory Pressure Increased
Previous 17.86%
Current 59.86%
Delta 42.00% Profitability Increased
Previous -29.66%
Current 6.09%
Delta 35.74% R And D Intensity Decreased
Previous 2.17%
Current 1.95%
Delta -0.22% Sbc Intensity Decreased
Previous 0.87%
Current 0.64%
Delta -0.23% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.